{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:47:36Z","timestamp":1783435656043,"version":"3.54.6"},"reference-count":48,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["N42\/DBS\/000045, N42\/DBS\/000138, N42\/DBS\/000039, N42\/DBS\/000139"],"award-info":[{"award-number":["N42\/DBS\/000045, N42\/DBS\/000138, N42\/DBS\/000039, N42\/DBS\/000139"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>GPR18 is an orphan GPCR that is activated by the cannabinoid tetrahydrocannabinol (THC). Emerging evidence indicates its involvement in the control of cardiovascular functions, including heart rate, contractility, vascular tone, as well as blood pressure. Therefore, we investigated the effects of selective GPR18 receptor ligands, namely PSB-KD-107 (agonist) and PSB-CB-92 (antagonist), on blood pressure, electrocardiogram (ECG), and vascular dilatation in vitro and in vivo, as well as their anti-oxidative potential in in vitro ferric reducing antioxidant power (FRAP) and 2,2-diphenyl-1-picryl-hydrazyl-hydrate free radical (DPPH) assays. Our results clearly show that PSB-KD-107 dilates blood vessels. This effect is related to its activation of GPR18 as it can be blocked by the GPR18 antagonist PSB-CB-92. Moreover, our finding confirms the presence of GPR18 in blood vessels. The mechanism of the vasorelaxant activity of PSB-KD-107 is mainly related to endothelial nitric oxide generation; however, we cannot exclude additional nitric oxide-independent mechanisms or a direct influence on K+ channels. PSB-KD-107 may affect blood pressure and heart function after a single administration; however, this effect was no longer observed after repeated administrations once daily for eight days. PSB-KD-107 does not affect platelet aggregation\u2014an important feature considering the safety of its administration. PSB-KD-107 also shows a significant anti-oxidant effect and further studies of its antioxidant activity in vivo are justified.<\/jats:p>","DOI":"10.3390\/ph14080799","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T09:22:38Z","timestamp":1628846558000},"page":"799","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3946-1192","authenticated-orcid":false,"given":"Magdalena","family":"Kota\u0144ska","sequence":"first","affiliation":[{"name":"Department of Pharmacological Screening, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4878-0723","authenticated-orcid":false,"given":"Monika","family":"Kubacka","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Bednarski","sequence":"additional","affiliation":[{"name":"Department of Pharmacological Screening, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9453-1237","authenticated-orcid":false,"given":"Noemi","family":"Nicosia","sequence":"additional","affiliation":[{"name":"Department of Pharmacological Screening, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland"},{"name":"Foundation \u201cProf. Antonio Imbesi\u201d, University of Messina, Piazza Pugliatti 1, 98122 Messina, Italy"},{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Palatucci, 98168 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Szafarz","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics and Physical Pharmacy, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-490X","authenticated-orcid":false,"given":"Wojciech","family":"Jawie\u0144","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biophysics, Faculty of Pharmacy, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-6624","authenticated-orcid":false,"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Pharma Center Bonn, Pharmaceutical & Medicinal Chemistry, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kie\u0107-Kononowicz","sequence":"additional","affiliation":[{"name":"Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","article-title":"Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities","volume":"367","author":"Pertwee","year":"2012","journal-title":"Phil. Trans. R. Soc. B"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.3892\/mmr.2016.5585","article-title":"Endocannabinoid system: Role in depression, reward and pain control (Revier)","volume":"14","author":"Huang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kota\u0144ska, M., Mika, K., Szafarz, M., Kubacka, M., M\u00fcller, C.E., Sapa, J., and Kie\u0107-Kononowicz, K. (2021). Effects of gpr18 ligands on body weight and metabolic parameters in a female rat model of excessive eating. Pharmaceuticals, 14.","DOI":"10.3390\/ph14030270"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1039\/C3MD00394A","article-title":"Bicyclic imidazole-4-one derivatives: A new class of antagonists for the orphan G Protein-coupled receptors GPR18 and GPR55","volume":"5","author":"Rempel","year":"2014","journal-title":"MedChemComm"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0165-6147(00)01482-6","article-title":"The endocannabinoid system as a target for therapeutic drugs","volume":"21","author":"Piomelli","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-030-57369-0_2","article-title":"Neuromolecular Mechanisms of Cannabis Action","volume":"1264","author":"Adel","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lfs.2018.09.058","article-title":"Cannabinoids in depressive disorders","volume":"213","author":"Poleszak","year":"2018","journal-title":"Life Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.apha.2017.04.004","article-title":"Cannabinoid receptor-related orphan G protein-coupled receptors","volume":"80","author":"Irving","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1124\/jpet.113.209213","article-title":"The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure","volume":"349","author":"Penumarti","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acsmedchemlett.0c00208","article-title":"Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18","volume":"11","author":"Schoeder","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejmech.2018.05.050","article-title":"Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18","volume":"155","author":"Schoeder","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mnfr.201500449","article-title":"G protein coupled receptor 18: A potential role for endocannaninoid signaling in metabolic dysfunction","volume":"60","author":"Rajaraman","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e14003","DOI":"10.1111\/nmo.14003","article-title":"Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain","volume":"33","author":"Fabisiak","year":"2021","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Neumann, A., Engel, V., Mahardhika, A.B., Schoeder, C.T., Namasivayam, V., Kie\u0107-Kononowicz, K., and M\u00fcller, C.E. (2020). Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18. Biomolecules, 10.","DOI":"10.3390\/biom10050686"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/FJC.0000000000000438","article-title":"The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats","volume":"69","author":"Matouk","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"Jarai","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1124\/mol.63.3.699","article-title":"Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor","volume":"63","author":"Offertaler","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2016.11.040","article-title":"The endogenous lipid N-arachidonyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant","volume":"794","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"663.10","DOI":"10.1096\/fasebj.26.1_supplement.663.10","article-title":"Role of central atypical cannabinoid receptor GPR18 in modulating cardiovascular funtion","volume":"26","author":"Penumarti","year":"2012","journal-title":"FASEB J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.7717\/peerj.1835","article-title":"GPR18 undergoes a high degree of con-stitutive trafficking but is unresponsive to N-Arachidonoyl Glycine","volume":"4","author":"Finlay","year":"2016","journal-title":"Peer J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000025659","article-title":"Relaxation in different-sized rat blood vessels mediated by endothelium-derived hyperpolarizing factor: Importance of processes mediating precontractions","volume":"36","author":"Tomioka","year":"1999","journal-title":"J. Vasc. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1540\/jsmr.44.65","article-title":"Physiological roles of K+ channels in vascular smooth muscle cells","volume":"44","author":"Ko","year":"2008","journal-title":"J. Smooth. Muscle Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1476-5381.2009.00622.x","article-title":"N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels","volume":"160","author":"Parmar","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/jpet.106.107375","article-title":"Determining the potency and molecular mechanism of action of insurmountable antagonists","volume":"319","author":"Kenakin","year":"2006","journal-title":"Pharmacol. Exp. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Haspula, D., and Clark, M.A. (2020). Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207693"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1016\/j.bmc.2007.07.051","article-title":"Phenylethyl-substituted pyrimido [2, 1-f] purinediones and related compounds: Structure\u2013activity relationships as adenosine A1 and A2A receptor ligands","volume":"15","author":"Schiedel","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jcp.27161","article-title":"Therapeutic potential of A2 adenosine receptor pharmacological regulators in the treatment of cardiovascular diseases, recent progress, and prospective","volume":"234","author":"Bahreyni","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wolska, N., and Rozalski, M. (2019). Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215475"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Atalay, S., Jarocka-karpowicz, I., and Skrzydlewskas, E. (2019). Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants, 9.","DOI":"10.3390\/antiox9010021"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Gao, F., Coppola, G., Geschwind, D., and Vogel, Z. (2013). Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061462"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/jpet.105.085779","article-title":"Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity","volume":"314","author":"Hamelink","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/glia.22345","article-title":"Cannabidiol-induced apoptosis in murine microglial cells through lipid raft","volume":"60","author":"Wu","year":"2012","journal-title":"Glia"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gugliandolo, A., Pollastro, F., Grassi, G., Bramanti, P., and Mazzon, E. (2018). In vitro model of neuroinflammation: Efficacy of cannabigerol, a non-psychoactive cannabinoid. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071992"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0269881109106925","article-title":"Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania","volume":"25","author":"Valvassori","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"12064","DOI":"10.1038\/s41598-017-10924-8","article-title":"Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u0394E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biopha.2018.04.034","article-title":"Involvement of the NO\/sGC\/cGMP\/K+ channels pathway in vascular relaxation evoked by two non-quinazoline \u03b11-adrenoceptor antagonists","volume":"103","author":"Kubacka","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pbb.2015.03.019","article-title":"Antinociceptive, anti-inflammatory and smooth muscle relaxant activities of the pyrrolo [3,4-d] pyridazinone derivatives: Possible mechanisms of action","volume":"133","author":"Mogilski","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00210-019-01783-3","article-title":"Antinociceptive, antiedematous, and antiallodynic activity of 1H-pyrrolo[3,4-c] pyridine-1,3(2H)-dione derivatives in experimental models of pain","volume":"393","author":"Dziubina","year":"2019","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"111164","DOI":"10.1016\/j.biopha.2020.111164","article-title":"PSB 603\u2014A known selective adenosine A2B receptor antagonist\u2013has anti-inflammatory activity in mice","volume":"135","author":"Mika","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kuder, K.J., Kota\u0144ska, M., Szczepa\u0144ska, K., Mika, K., Reiner-Link, D., Stark, H., and Kie\u0107-Kononowicz, K. (2021). Discovery of Potential, Dual-Active Histamine H3 Receptor Ligands with Combined Antioxidant Properties. Molecules, 26.","DOI":"10.3390\/molecules26082300"},{"key":"ref_45","first-page":"25","article-title":"Use of a free radical method to evaluate antioxidant activity","volume":"28","author":"Cuvelier","year":"1995","journal-title":"Food Sci. Technol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","article-title":"Ferric reducing\/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration","volume":"299","author":"Benzie","year":"1999","journal-title":"Methods Enzymol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40618-017-0779-7","article-title":"Metabolic benefits of 1-(3-(4-(o-tolyl) piperazin-1-yl) propyl) pyrrolidin-2-one: A non-selective \u03b1-adrenoceptor antagonist","volume":"41","author":"Kulig","year":"2018","journal-title":"J. Endocrinol. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1472-8206.2002.00081.x","article-title":"In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: Application to the preclinical cardiovascular safety pharmacology of a new chemical entity","volume":"16","author":"Lu","year":"2002","journal-title":"Fundam. Clin. Pharmacol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/8\/799\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:45:18Z","timestamp":1760165118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/8\/799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ph14080799"],"URL":"https:\/\/doi.org\/10.3390\/ph14080799","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]}}}